$221.38—Stale · unknown old
NASDAQ • Last print unknown ago
$221.38—Stale · unknown old
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight
Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025
Merck expects over $5 billion commercial opportunity from Cidara's flu drug
Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher
This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics
Merck nearing deal for Cidara, FT reports